Abstract |
A variety of medications representing several major drug classes improve cataplexy in patients with narcolepsy. These include aminergic reuptake inhibitors such as venlafaxine and clomipramine as well as sodium oxybate. This review is intended to familiarize readers with the safety and efficacy of these medications, thus enabling clinicians to optimize their management of cataplexy.
|
Authors | William C Houghton, Thomas E Scammell, Michael Thorpy |
Journal | Sleep medicine reviews
(Sleep Med Rev)
Vol. 8
Issue 5
Pg. 355-66
(Oct 2004)
ISSN: 1087-0792 [Print] England |
PMID | 15336236
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antidepressive Agents
- Central Nervous System Stimulants
- Cyclohexanols
- Venlafaxine Hydrochloride
- Sodium Oxybate
- Clomipramine
|
Topics |
- Antidepressive Agents
(adverse effects, therapeutic use)
- Cataplexy
(drug therapy)
- Central Nervous System Stimulants
(adverse effects, therapeutic use)
- Clinical Trials as Topic
- Clomipramine
(adverse effects, therapeutic use)
- Cyclohexanols
(adverse effects, therapeutic use)
- Humans
- Long-Term Care
- Sodium Oxybate
(adverse effects, therapeutic use)
- Treatment Outcome
- Venlafaxine Hydrochloride
|